Literature DB >> 26713883

Gorham-Stout Disease of the Skull Base With Hearing Loss: Dramatic Recovery and Antiangiogenic Therapy.

Akifumi Nozawa1, Michio Ozeki1, Bunya Kuze2, Takahiko Asano3, Kentaro Matsuoka4, Toshiyuki Fukao1.   

Abstract

Gorham-Stout disease (GSD) is a rare disorder of unknown etiology. We present a 6-year-old male with GSD involving the skull base who presented with recurrent cerebrospinal fluid (CSF) rhinorrhea, severe hearing loss, and facial palsy secondary to cerebellar herniation into the internal auditory canal. After 2 months of treatment with pegylated interferon (IFN) α-2b (50 μg/week), his hearing recovered dramatically. Two years later, new bone formation appeared radiologically and IFN was switched to sirolimus. One year after the switch, CSF rhinorrhea disappeared. Antiangiogenic therapy might inhibit proliferation of vascular endothelial cells in osteolytic lesions and lead to new bone formation.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cerebrospinal fluid leakage; interferon; lymphatic malformation; mammalian target of rapamycin; sirolimus

Mesh:

Substances:

Year:  2015        PMID: 26713883     DOI: 10.1002/pbc.25886

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Gorham-Stout case report: a multi-omic analysis reveals recurrent fusions as new potential drivers of the disease.

Authors:  Marcos Yébenes Mayordomo; Sofian Al Shboul; Maria Gómez-Herranz; Asim Azfer; Alison Meynert; Donald Salter; Larry Hayward; Anca Oniscu; James T Patton; Ted Hupp; Mark J Arends; Javier Antonio Alfaro
Journal:  BMC Med Genomics       Date:  2022-06-06       Impact factor: 3.622

2.  Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies-Insights From a Retrospective Case Series.

Authors:  Anna Karastaneva; Paolo Gasparella; Sebastian Tschauner; Roman Crazzolara; Gabriele Kropshofer; Manfred Modl; Andreas Pfleger; Ante Burmas; Mirjam Pocivalnik; Raphael Ulreich; Werner Zenz; Wolfgang Schwinger; Besiana P Beqo; Christian Urban; Emir Q Haxhija; Herwig Lackner; Martin Benesch
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

3.  Primary versus trauma-induced Gorham-Stout disease.

Authors:  N Tanoue; L Moedano; M Witte; M Montague; A Lukefahr; M Bernas
Journal:  Lymphology       Date:  2018       Impact factor: 1.286

4.  Gorham Stout disease of the temporal bone with cerebrospinal fluid leak.

Authors:  Pascale Aouad; Nancy M Young; Amanda M Saratsis; Meredith A Reynolds; Maura E Ryan
Journal:  Childs Nerv Syst       Date:  2021-06-11       Impact factor: 1.475

5.  Sirolimus on Gorham-Stout disease. Case report.

Authors:  Vanessa García; Gloria Alonso-Claudio; M-Teresa Gómez-Hernández; Antonio-J Chamorro
Journal:  Colomb Med (Cali)       Date:  2016-12-30

Review 6.  Current concepts from diagnosis to management in Gorham-Stout disease: a systematic narrative review of about 350 cases.

Authors:  Andrea Angelini; Nicolò Mosele; Elisa Pagliarini; Pietro Ruggieri
Journal:  EFORT Open Rev       Date:  2022-01-11

7.  Endoscopic Endonasal Dural Reconstruction for a Cerebrospinal Fluid Leak in the Middle Cranial Fossa of a Patient with Gorham-stout Disease with Skull Base Defect.

Authors:  Yusuke Morinaga; Hiroyoshi Akutsu; Hiroyoshi Kino; Shuho Tanaka; Hidetaka Miyamoto; Masahide Matsuda; Eiichi Ishikawa
Journal:  NMC Case Rep J       Date:  2022-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.